Original Article

Establishment of Antibody-dependant Cellular Cytotoxicity against Human Squamous Cell Carcinoma of Head and Neck and The Effect of Prostaglandin on Antibody-dependant Cellular Cytotoxicity

Chun Dong Kim, Sung Wan Byun, Soon Kwan Hong
Author Information & Copyright
Department of Otolaryngology, College of Medicine, Ewha Womans University, Korea.

Copyright ⓒ 1998. Ewha Womans University School of Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: Sep 30, 1998

Abstract

Background

Head and neck squamous cell carcinoma(HNSCC) has been associated with host immunosuppression, including depressed T-lymphocyte and natural killer cell function. This immunosuppression has been shown to be most pronounced in the locoregional environment of the tumor and appears to be mediated by soluble suppressor factor prostaglandinE2(PGE2). PGE2 is a product of cell membrane phospholipid metabolism that is known to have potent immunoregulatory activity including inhibition of natural killer cell activity and antibody dependent cell mediated cytotoxicity(ADCC).

Method

In our experiment, we have established an ADCC assay with IgGl cMAB SF-25, 323A/3 using human squamous cell carcinoma of the head and neck cell line(PCI-50) as target. The measurement of cytotoxicity was determined by measuring the release of 51Chromium from the target cells after 4 hour incubation.

Result

PGE2 inhibited antibody dependant cell mediated cytotoxicity.

Conclusion

It thus implies that the production of prostaglandins by tumor cells may constitute a means by which the tumor cells subvert the effect of a cellular immune response that is directed against them and arming of NK cells with chimeric antibody could be considered in developing means for treatment of human SCCHN in adjuvant setting.

Keywords: ADCC; PG; SCCHN